Marking the second in the prestigious series of talks: VHIO Meet the Editors, Science´s Paula Kiberstis, Senior Editor, cancer research, will be joining us to deliver what promises to be a highly insightful presentation on Demystifying Science.
en_news
The BBVA Foundation Tumor Biomarkers Research Program unites Massachusetts General Hospital Cancer Center and Vall d’Hebron Institute of Oncology in the search for personalized cancer therapies
Aflibercept vs placebo and FOLFIRI for MCRC
VHIO and 27 other leading European Cancer Institutes are working together in a unique collaboration to share infrastructures and collaborate on projects to help advance cancer research and treatment: EurocanPlatform
CONFIRMATION THAT VITAMIN D ACTS AS A PROTECTIVE AGENT AGAINST THE ADVANCE OF COLON CANCER A study conducted by…
In a joint ecancermedicalscience interview filmed at ASCO 2011 in Chicago, José Baselga and Josep Tabernero describe the early beginnings…
Recently captured at the 2011 ASCO meeting, Joan Seoane, Director of the Vall d´Hebron Institute of Oncology´s (VHIO) Translational Research Programme talks to ecancermedicalscience
Principle Investigator of VHIO´s Mouse Models of Cancer Therapy Group, Laura Soucek has been awarded this year´s Fero (Fundación de Investigación Oncológica) grant for translational cancer research for her pioneering work using mouse models to counteract tumoral activity triggered by ´the oncogene from Hell´*, Myc.
